Pharmacology, Toxicology and Pharmaceutical Science
Drug Resistant Tuberculosis
100%
Hydroxychloroquine Sulfate
100%
Therapeutic Drug Monitoring
100%
Extensively Drug-Resistant Tuberculosis
100%
Tolerability
100%
Normal Human
100%
Pharmacokinetics
100%
Hydroxychloroquine
100%
Multi-Drug-Resistant Tuberculosis
66%
Linezolid
33%
Rifampicin
33%
Mixed Infection
33%
Vaccination Policy
33%
Comorbidity
33%
Bedaquiline
33%
Quinolone Derivative
33%
Disease Severity
33%
Drug Administration
33%
Isoniazid
33%
Cyclopia
14%
Dry Powder Inhaler
14%
Pharmacokinetic Parameter
14%
Adverse Event
14%
Side Effect
14%
Infection
14%
Toxicity
14%
Coughing
14%
Antiinfective Agent
14%
SARS Coronavirus
14%
Keyphrases
Multidrug-resistant Tuberculosis (MDR-TB)
100%
Hydroxychloroquine Sulfate
100%
Tuberculosis Care
100%
Drug Exposure
60%
Therapeutic Drug Monitoring
60%
XDR-TB
40%
Loss-of-susceptibility
40%
Gender Composition
20%
Disease Severity
20%
TB Drugs
20%
Fluoroquinolones
20%
Appropriate Technology
20%
Comorbidity
20%
Nutritional Status
20%
Intra-individual
20%
Low-resource Settings
20%
Co-infection
20%
Drug Administration
20%
Surgical Intervention
20%
Therapeutic Vaccination
20%
Extensively Drug-resistant Tuberculosis
20%
Body Composition
20%
Blood Samples
20%
Bedaquiline
20%
Minimum Inhibitory Concentration
20%
Rifampicin
20%
Host-directed Therapy
20%
Genetic Background
20%
Linezolid
20%
Orally Administration
14%
Intrapulmonary Pharmacokinetics
14%
